• Dextrose gel in sterile syringe

    DexProNeo is an easy to administer and cost effective medicinal product for hypoglycaemic newborns

    Make an appointment

  • Dextrose gel in sterile syringe

Up to 15% of all healthy newborns suffer from hypoglycaemia.



Learn more

Easy dosing of dextrose gel in a sterile and ready to administer syringe! This simple solution changes the treatment of hypoglycaemic newborns drastically.


Learn more

The evidence is clear! Scientific research show the effectiveness of administering dextrose gel to hypoglycaemic newborns.


Learn more

Ready to administer

Easy dosing syringe

LESS SEPARATION

Less separation newborn and mother, less newborns to NICU

STERILE

Sterile, no preservatives

SAVING

Time and costs saving

Interview

Prof. Dr. Irwin Reiss

Head of department of Neonatology Erasmus MC

(Click on video below)

Interview

Dr. Sinno Simons

Neonatologist Erasmus MC

(Click on video below)

DO WELL BY DOING GOOD

(Benjamin Franklin)

About the company BioProNeo B.V.

BioProNeo B.V. is a Dutch limited company, established in 2016 by entrepreneurs with different backgrounds but 1 common goal: Do well by doing good.

The management team, consisting of Edwin Spaans (clinical pharmacologist), Martin Gouw (registered pharmacist), Floris Jan van Brederode (IT specialist) and Mirena Nouwen (drug development professional), have joined forces to develop and distribute pharmaceuticals and/or nutraceuticals to support newborn care: driven by medical need, building on existing evidence.